MX9709716A - Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos. - Google Patents

Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos.

Info

Publication number
MX9709716A
MX9709716A MX9709716A MX9709716A MX9709716A MX 9709716 A MX9709716 A MX 9709716A MX 9709716 A MX9709716 A MX 9709716A MX 9709716 A MX9709716 A MX 9709716A MX 9709716 A MX9709716 A MX 9709716A
Authority
MX
Mexico
Prior art keywords
dry
methods
compositions obtained
foamed glass
stably incorporating
Prior art date
Application number
MX9709716A
Other languages
English (en)
Inventor
Bruce Joseph Roser
Enda Martin Gribbon
Original Assignee
Quadrant Holdings Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9709716(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadrant Holdings Cambridge filed Critical Quadrant Holdings Cambridge
Publication of MX9709716A publication Critical patent/MX9709716A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La invencion proporciona métodos para producir vidrio celular y las composiciones obtenidas mediante los mismos. Las composiciones son adecuadas para un almacenamiento estable de una amplia variedad de substancias, en particular biologicas y farmacéuticas.
MX9709716A 1995-06-07 1996-06-07 Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos. MX9709716A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07
PCT/GB1996/001367 WO1996040077A2 (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Publications (1)

Publication Number Publication Date
MX9709716A true MX9709716A (es) 1998-03-31

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9709716A MX9709716A (es) 1995-06-07 1996-06-07 Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos.

Country Status (22)

Country Link
EP (1) EP0831790B1 (es)
JP (1) JP4502406B2 (es)
KR (1) KR19990022710A (es)
CN (1) CN1245957C (es)
AP (1) AP852A (es)
AT (1) ATE239451T1 (es)
AU (1) AU713599B2 (es)
BR (1) BR9609188A (es)
CA (1) CA2223438C (es)
CZ (1) CZ391297A3 (es)
DE (1) DE69628007T2 (es)
DK (1) DK0831790T3 (es)
ES (1) ES2194992T3 (es)
HU (1) HUP9901716A3 (es)
IL (1) IL122482A (es)
MX (1) MX9709716A (es)
NO (1) NO975773L (es)
NZ (1) NZ309841A (es)
PL (1) PL184823B1 (es)
PT (1) PT831790E (es)
SK (1) SK167597A3 (es)
WO (1) WO1996040077A2 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69530196T2 (de) 1994-06-02 2003-11-20 Elan Drug Delivery Ltd Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
CA2312233A1 (en) * 1997-11-26 1999-06-03 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1071465A1 (en) * 1998-03-18 2001-01-31 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
BR0010249A (pt) * 1999-05-04 2002-02-13 Eric Edward Worrall Processo para a preservação de vìrus e micoplasma
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
CA2382061A1 (en) * 1999-08-19 2001-02-22 Victor Bronshtein Preservation of bacterial cells at ambient temperatures
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
SI1296656T1 (sl) * 2000-06-27 2006-12-31 Hoffmann La Roche Postopek priprave sestavka
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
EP1455822A4 (en) * 2001-11-09 2004-12-29 Centocor Inc LYOPHILIZED MONOCLONAL ANTIBODY COMPOSITIONS
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
DK2395073T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying.
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
GB0409795D0 (en) 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
WO2005116081A2 (en) * 2004-05-24 2005-12-08 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form
CA2569276C (en) 2004-06-02 2018-01-23 Victor Bronshtein Preservation by vaporization
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
CN105147611A (zh) * 2007-07-26 2015-12-16 圣诺菲·帕斯图尔有限公司 抗原佐剂组合物及其方法
WO2010031007A2 (en) 2008-09-12 2010-03-18 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
MX2011012586A (es) 2009-05-26 2012-03-26 Advanced Bionutrition Corp Composicion de polvo seco estable que comprende microorganismos biologicamente activos y/o materiales bioactivos y metodos de elaboracion.
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
RU2535869C2 (ru) 2010-01-28 2014-12-20 Эдванст Бионутришн Корпорейшн Сухая стекловидная композиция для стабилизации и защиты биологически активного материала и способ ее получения
CN103140145B (zh) 2010-08-13 2014-08-20 高级生物营养公司 用于生物材料的干的贮存稳定用组合物
US20120219590A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
CA2836273C (en) * 2011-05-17 2019-01-15 Soligenix, Inc. Thermostable vaccine compositions and methods of preparing same
EA037797B1 (ru) 2011-10-25 2021-05-21 Протена Байосайенсиз Лимитед Состав антитела, пригодный для профилактики и лечения амилоидоза, его варианты и способ его получения
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
AU2016297986B8 (en) 2015-07-29 2020-06-11 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
ES2818569T3 (es) * 2015-09-09 2021-04-13 Drawbridge Health Inc Métodos para la recopilación, estabilización y conservación de muestras
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
KR20190116979A (ko) 2017-01-10 2019-10-15 드로브릿지 헬스, 인크. 샘플 수집을 위한 장치, 시스템, 및 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
JPS6115830A (ja) * 1984-06-28 1986-01-23 ザ　プロクタ−　アンド　ガンブル　カンパニ− 制酸剤組成物およびその製造方法
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
DE69004927T2 (de) * 1989-05-01 1994-06-30 Baxter Int Zusammensetzung eines heilmittels und verfahren zur verabreichung bei einer kontrollierten lösungsgeschwindigkeit.
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
WO1993010758A1 (en) * 1991-12-05 1993-06-10 Pitman-Moore, Inc. A carbohydrate glass matrix for the sustained release of a therapeutic agent
EP0620728B1 (en) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation of tablets of increased strength
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
AU2531295A (en) * 1994-05-27 1995-12-21 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
NO975773D0 (no) 1997-12-08
AU713599B2 (en) 1999-12-09
DE69628007D1 (de) 2003-06-12
JPH11506467A (ja) 1999-06-08
WO1996040077A3 (en) 1997-01-23
AU6009896A (en) 1996-12-30
AP852A (en) 2000-06-16
IL122482A0 (en) 1998-06-15
HUP9901716A2 (hu) 1999-09-28
IL122482A (en) 1999-10-28
BR9609188A (pt) 1999-05-11
JP4502406B2 (ja) 2010-07-14
WO1996040077A2 (en) 1996-12-19
AP9701151A0 (en) 1998-01-31
DE69628007T2 (de) 2003-11-27
HUP9901716A3 (en) 2000-04-28
CZ391297A3 (cs) 1998-05-13
ES2194992T3 (es) 2003-12-01
PL184823B1 (pl) 2002-12-31
EP0831790B1 (en) 2003-05-07
CN1193908A (zh) 1998-09-23
PT831790E (pt) 2003-07-31
CA2223438A1 (en) 1996-12-19
CA2223438C (en) 2008-05-13
NO975773L (no) 1998-02-03
DK0831790T3 (da) 2003-09-01
ATE239451T1 (de) 2003-05-15
SK167597A3 (en) 1998-10-07
NZ309841A (en) 1999-10-28
KR19990022710A (ko) 1999-03-25
EP0831790A2 (en) 1998-04-01
CN1245957C (zh) 2006-03-22
PL323902A1 (en) 1998-04-27

Similar Documents

Publication Publication Date Title
MX9709716A (es) Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos.
EP0836649A4 (en) CELL-FREE POLYCETIDE SYNTHESIS
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
AU3310595A (en) Compositions and methods for identifying biologically active molecules
AU1111695A (en) Composition for the production of therapeutic products in vivo
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
CA2285430A1 (en) Calcium phosphate microcarriers and microspheres
AU6914894A (en) Process for the manufacture of 1,1,1,2,3-pentafluoropropane
CA2159055A1 (en) Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
AU6477390A (en) Gas generating compositions containing nitrotriazalone
UA42795C2 (uk) Протизапальний засіб для зовнішнього застосування, що містить німесулід, і спосіб його одержання
AU5214096A (en) Pharmaceutical composition containing substance inhibiting HSP47 production
HUP9802323A3 (en) Pyrimidine derivatives , process for producing them and pharmaceutical compositions containing them
CA2222425A1 (en) Immortalization and disimmortalization of cells
IL119488A0 (en) Substituted 2,4-imidazolidinediones their production and pharmaceutical compositions containing them
AU8748498A (en) Photocatalyst composition, substance containing photocatalyst, and material functioning as photocatalyst and process for producing the same
WO1998028317A3 (en) Synthesis of nucleosides and polynucleotides
IL117940A (en) Benzylsulfide derivatives, process for their production and insecticide compositions containing them
HUP9601358A2 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
HUP9602640A2 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
CA2269077A1 (en) Keratinocyte growth factor-2 products
AU588577B2 (en) Storage stable, foamable tow-part polyorganosiloxane compositions
HUP9602748A3 (en) Novel n-pyrimidinyl-sulfonamides, process for producing them and pharmaceutical compositions containing them
AU4627996A (en) Fragrance self supporting gel compositions
HU9503932D0 (en) Substituted benzol-sulfonyl-ureas and-thioureas, pharmaceutical compositions containing them and process for producing them

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees